Novo Nordisk AS
Kurs
Diff. Vortag in %
52 Wochen Tief
52 Wochen Hoch
- Eher Negativ
- Seit dem 03.03.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 250,30 270 | 250,30 | 270 | 7,870555 | BARCLAYS | ||
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 250,30 260 | 250,30 | 260 | 3,87535 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 250,30 270 | 250,30 | 270 | 7,870555 | BARCLAYS | ||
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 250,30 270 | 250,30 | 270 | 7,870555 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 250,30 400 | 250,30 | 400 | 59,80823 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 250,30 250 | 250,30 | 250 | 0,119856 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 250,30 400 | 250,30 | 400 | 59,80823 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 250,30 332 | 250,30 | 332 | 32,640831 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 250,30 340 | 250,30 | 340 | 35,836996 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 250,30 275 | 250,30 | 275 | 9,868158 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 250,30 350 | 250,30 | 350 | 39,832201 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 250,30 340 | 250,30 | 340 | 35,836996 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 250,30 275 | 250,30 | 275 | 9,868158 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 250,30 250 | 250,30 | 250 | 0,119856 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 250,30 270 | 250,30 | 270 | 7,870555 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 250,30 340 | 250,30 | 340 | 35,836996 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 250,30 340 | 250,30 | 340 | 35,836996 | BARCLAYS | ||
| Novo Nordisk AS | 17.02.2026 0 Monate | 17.02.2026 | 0 Monate | 250,30 340 | 250,30 | 340 | 35,836996 | BARCLAYS | ||
| Novo Nordisk AS | 12.02.2026 0 Monate | 12.02.2026 | 0 Monate | 250,30 340 | 250,30 | 340 | 35,836996 | BARCLAYS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 250,30 400 | 250,30 | 400 | 59,80823 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 250,30 275 | 250,30 | 275 | 9,868158 | JEFFERIES | ||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 250,30 360 | 250,30 | 360 | 43,827407 | BERENBERG | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 250,30 360 | 250,30 | 360 | 43,827407 | BARCLAYS | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 250,30 360 | 250,30 | 360 | 43,827407 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 250,30 350 | 250,30 | 350 | 39,832201 | JPMORGAN | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 250,30 332 | 250,30 | 332 | 32,640831 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 250,30 475 | 250,30 | 475 | 89,772273 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 250,30 332 | 250,30 | 332 | 32,640831 | UBS | ||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 250,30 350 | 250,30 | 350 | 39,832201 | JPMORGAN | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 250,30 270 | 250,30 | 270 | 7,870555 | JEFFERIES | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 250,30 350 | 250,30 | 350 | 39,832201 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 250,30 350 | 250,30 | 350 | 39,832201 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 250,30 360 | 250,30 | 360 | 43,827407 | BARCLAYS | ||
| Novo Nordisk AS | 01.02.2026 0 Monate | 01.02.2026 | 0 Monate | 250,30 390 | 250,30 | 390 | 55,813024 | UBS | ||
| Novo Nordisk AS | 29.01.2026 0 Monate | 29.01.2026 | 0 Monate | 250,30 350 | 250,30 | 350 | 39,832201 | JPMORGAN | ||
| Novo Nordisk AS | 23.01.2026 12 Monate | 23.01.2026 | 12 Monate | 250,30 270 | 250,30 | 270 | 7,870555 | JEFFERIES |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 22.01.2026 12 Monate | 22.01.2026 | 12 Monate | 250,30 436 | 250,30 | 436 | 74,190971 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 22.01.2026 0 Monate | 22.01.2026 | 0 Monate | 250,30 415 | 250,30 | 415 | 65,801039 | BERENBERG | ||
| Novo Nordisk AS | 21.01.2026 12 Monate | 21.01.2026 | 12 Monate | 250,30 360 | 250,30 | 360 | 43,827407 | BARCLAYS | ||
| Novo Nordisk AS | 20.01.2026 12 Monate | 20.01.2026 | 12 Monate | 250,30 270 | 250,30 | 270 | 7,870555 | JEFFERIES | ||
| Novo Nordisk AS | 20.01.2026 0 Monate | 20.01.2026 | 0 Monate | 250,30 390 | 250,30 | 390 | 55,813024 | UBS | ||
| Novo Nordisk AS | 19.01.2026 0 Monate | 19.01.2026 | 0 Monate | 250,30 390 | 250,30 | 390 | 55,813024 | UBS | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 250,30 360 | 250,30 | 360 | 43,827407 | BARCLAYS | ||
| Novo Nordisk AS | 15.01.2026 0 Monate | 15.01.2026 | 0 Monate | 250,30 415 | 250,30 | 415 | 65,801039 | BERENBERG | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 250,30 475 | 250,30 | 475 | 89,772273 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 250,30 350 | 250,30 | 350 | 39,832201 | JPMORGAN | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 250,30 390 | 250,30 | 390 | 55,813024 | UBS | ||
| Novo Nordisk AS | 09.01.2026 12 Monate | 09.01.2026 | 12 Monate | 250,30 400 | 250,30 | 400 | 59,80823 | BERENBERG |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 07.01.2026 12 Monate | 07.01.2026 | 12 Monate | 250,30 400 | 250,30 | 400 | 59,80823 | BERENBERG | ||
| Novo Nordisk AS | 06.01.2026 12 Monate | 06.01.2026 | 12 Monate | 250,30 360 | 250,30 | 360 | 43,827407 | BARCLAYS | ||
| Novo Nordisk AS | 02.01.2026 0 Monate | 02.01.2026 | 0 Monate | 250,30 350 | 250,30 | 350 | 39,832201 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 250,30 475 | 250,30 | 475 | 89,772273 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.12.2025 12 Monate | 16.12.2025 | 12 Monate | 250,30 350 | 250,30 | 350 | 39,832201 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 250,30 475 | 250,30 | 475 | 89,772273 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12.12.2025 0 Monate | 12.12.2025 | 0 Monate | 250,30 295 | 250,30 | 295 | 17,85857 | UBS | ||
| Novo Nordisk AS | 11.12.2025 0 Monate | 11.12.2025 | 0 Monate | 250,30 295 | 250,30 | 295 | 17,85857 | UBS | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 250,30 350 | 250,30 | 350 | 39,832201 | JPMORGAN | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 250,30 352 | 250,30 | 352 | 40,631243 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 04.12.2025 0 Monate | 04.12.2025 | 0 Monate | 250,30 400 | 250,30 | 400 | 59,80823 | BERENBERG | ||
| Novo Nordisk AS | 03.12.2025 0 Monate | 03.12.2025 | 0 Monate | 250,30 295 | 250,30 | 295 | 17,85857 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 30.11.2025 0 Monate | 30.11.2025 | 0 Monate | 250,30 270 | 250,30 | 270 | 7,870555 | JEFFERIES | ||
| Novo Nordisk AS | 28.11.2025 12 Monate | 28.11.2025 | 12 Monate | 250,30 375 | 250,30 | 375 | 49,820216 | BARCLAYS | ||
| Novo Nordisk AS | 28.11.2025 0 Monate | 28.11.2025 | 0 Monate | 250,30 315 | 250,30 | 315 | 25,848981 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 250,30 475 | 250,30 | 475 | 89,772273 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.11.2025 12 Monate | 26.11.2025 | 12 Monate | 250,30 353 | 250,30 | 353 | 41,030763 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 250,30 475 | 250,30 | 475 | 89,772273 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 25.11.2025 0 Monate | 25.11.2025 | 0 Monate | 250,30 500 | 250,30 | 500 | 99,760288 | JPMORGAN | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 250,30 500 | 250,30 | 500 | 99,760288 | JPMORGAN | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 250,30 290 | 250,30 | 290 | 15,860967 | JEFFERIES | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 250,30 375 | 250,30 | 375 | 49,820216 | BARCLAYS | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 250,30 391 | 250,30 | 391 | 56,212545 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.11.2025 0 Monate | 24.11.2025 | 0 Monate | 250,30 | 250,30 | -- | DZ BANK |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 17.11.2025 0 Monate | 17.11.2025 | 0 Monate | 250,30 315 | 250,30 | 315 | 25,848981 | UBS | ||
| Novo Nordisk AS | 13.11.2025 0 Monate | 13.11.2025 | 0 Monate | 250,30 400 | 250,30 | 400 | 59,80823 | BERENBERG | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 250,30 475 | 250,30 | 475 | 89,772273 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 250,30 600 | 250,30 | 600 | 139,712345 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 250,30 | 250,30 | -- | DZ BANK | |||
| Novo Nordisk AS | 10.11.2025 0 Monate | 10.11.2025 | 0 Monate | 250,30 315 | 250,30 | 315 | 25,848981 | UBS | ||
| Novo Nordisk AS | 07.11.2025 0 Monate | 07.11.2025 | 0 Monate | 250,30 315 | 250,30 | 315 | 25,848981 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 250,30 600 | 250,30 | 600 | 139,712345 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 250,30 391 | 250,30 | 391 | 56,212545 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.11.2025 0 Monate | 06.11.2025 | 0 Monate | 250,30 540 | 250,30 | 540 | 115,741111 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 250,30 290 | 250,30 | 290 | 15,860967 | JEFFERIES | ||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 250,30 500 | 250,30 | 500 | 99,760288 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 05.11.2025 12 Monate | 05.11.2025 | 12 Monate | 250,30 500 | 250,30 | 500 | 99,760288 | JPMORGAN | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 250,30 290 | 250,30 | 290 | 15,860967 | JEFFERIES | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 250,30 340 | 250,30 | 340 | 35,836996 | UBS | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 250,30 540 | 250,30 | 540 | 115,741111 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 250,30 315 | 250,30 | 315 | 25,848981 | UBS | ||
| Novo Nordisk AS | 04.11.2025 0 Monate | 04.11.2025 | 0 Monate | 250,30 540 | 250,30 | 540 | 115,741111 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 250,30 600 | 250,30 | 600 | 139,712345 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 30.10.2025 0 Monate | 30.10.2025 | 0 Monate | 250,30 540 | 250,30 | 540 | 115,741111 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 24.10.2025 0 Monate | 24.10.2025 | 0 Monate | 250,30 290 | 250,30 | 290 | 15,860967 | JEFFERIES | ||
| Novo Nordisk AS | 22.10.2025 12 Monate | 22.10.2025 | 12 Monate | 250,30 600 | 250,30 | 600 | 139,712345 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 21.10.2025 0 Monate | 21.10.2025 | 0 Monate | 250,30 540 | 250,30 | 540 | 115,741111 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 21.10.2025 0 Monate | 21.10.2025 | 0 Monate | 250,30 340 | 250,30 | 340 | 35,836996 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 20.10.2025 0 Monate | 20.10.2025 | 0 Monate | 250,30 540 | 250,30 | 540 | 115,741111 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 17.10.2025 12 Monate | 17.10.2025 | 12 Monate | 250,30 500 | 250,30 | 500 | 99,760288 | JPMORGAN | ||
| Novo Nordisk AS | 16.10.2025 0 Monate | 16.10.2025 | 0 Monate | 250,30 540 | 250,30 | 540 | 115,741111 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 10.10.2025 12 Monate | 10.10.2025 | 12 Monate | 250,30 600 | 250,30 | 600 | 139,712345 | DEUTSCHE BANK RESEARCH |
News
Aktuell
Novo Nordisk: mehr als nur Abnehmspritzen – die Chance nach dem Kursrutsch?
Der dänische Pharmakonzern Novo Nordisk dominiert mit den Blockbustern Ozempic und Wegovy (Wirkstoff Semaglutid) den milliardenschweren Markt für Diabetes- und Adipositas-Medikamente. Jüngste Gewinnwarnungen, wachsende Konkurrenz (insbesondere durch Eli Lilly) und regulatorische Unsicherheiten (Nachahmerpräparate, Preisdruck) haben die Aktie stark unter Druck gebracht.
DZ BANK Produktauswahl
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Optionsscheine Classic Short
Produktauswahl : Basiswert Novo Nordisk AS
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M